Progenity Inc
NASDAQ:PROG
Progenity Inc
Capital Expenditures
Progenity Inc
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Progenity Inc
NASDAQ:PROG
|
Capital Expenditures
-$850k
|
CAGR 3-Years
44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Capital Expenditures
-$541.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
11%
|
CAGR 10-Years
1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Capital Expenditures
-$385m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-4%
|
|
CVS Health Corp
NYSE:CVS
|
Capital Expenditures
-$2.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
Cigna Corp
NYSE:CI
|
Capital Expenditures
-$1.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-10%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Capital Expenditures
-$493.5m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-9%
|
See Also
What is Progenity Inc's Capital Expenditures?
Capital Expenditures
-850k
USD
Based on the financial report for Dec 31, 2021, Progenity Inc's Capital Expenditures amounts to -850k USD.
What is Progenity Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
44%
Over the last year, the Capital Expenditures growth was 83%. The average annual Capital Expenditures growth rates for Progenity Inc have been 44% over the past three years .